New insights into understanding cardiometabolic risk. Introduction.
Fonarow
Gregg C
GC
Ahmanson-UCLA Cardiomyopathy Center, UCLA Preventive Cardiology Program, UCLA Division of Cardiology, Los Angeles, California, USA.
Watson
Karol E
KE
D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000209:etiology* / Q000517:prevention & control; D050171:Dyslipidemias / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000150:complications* / Q000628:therapy; D009765:Obesity / Q000150:complications; D018570:Risk Assessment; D012307:Risk Factors